Cite
HARVARD Citation
Chen, C. et al. (2022). Evaluation of the Pharmacokinetics of Felcisetrag (TAK‐954), a 5‐HT4 Receptor Agonist, in the Presence and Absence of Itraconazole, a Potent CYP3A4 Inhibitor. Clinical pharmacology in drug development. 11 (2), pp. 142-149. [Online].